Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021

被引:8
|
作者
Yang, Hong [1 ]
Qi, Qi [2 ]
Zhang, Yong [3 ]
Wen, Ning [1 ]
Cao, Lei [1 ]
Liu, Yu [2 ]
Fan, Chunxiang [1 ]
Yan, Dongmei [3 ]
Zhu, Xiaoping [2 ]
Hao, Lixin [1 ]
Zhu, Shuangli [3 ]
Ma, Qianli [2 ]
Liu, Jiajie [2 ]
Ma, Chao [1 ]
Nan, Lei [4 ]
Chen, Yong [5 ]
Ma, Xiaozhen [2 ]
Chen, Na [2 ]
Deng, Kun [4 ]
Shao, Ge [6 ]
Ding, Xianxiang [6 ]
An, Zhijie [1 ]
Rodewald, Lance E. [1 ]
Li, Xiaolei [3 ]
Wang, Dongyan [3 ]
Zhu, Hui [3 ]
Wang, Huaqing [1 ]
Feng, Zijian [7 ]
Xu, Wenbo [3 ]
Zhou, Jiushun [2 ]
Yin, Zundong [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, 27 Nan Wei Rd, Beijing 100050, Peoples R China
[2] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, Beijing, Peoples R China
[4] Liangshan Prefectural Ctr Dis Control & Prevent, Liangshan, Peoples R China
[5] Leibo Cty Ctr Dis Control & Prevent, Liangshan, Peoples R China
[6] Chinese Field Epidemiol Training Program, Beijing, Peoples R China
[7] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
关键词
IMMUNOGENICITY; OUTBREAK; SAFETY;
D O I
10.1001/jamanetworkopen.2022.49710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio outbreak response in certain situations. OBJECTIVE To investigate the response to a type 2 vaccine-derived poliovirus (VDPV2) outbreak. DESIGN, SETTING, AND PARTICIPANTS This case series was conducted in China after a VDPV2 was detected in stool specimens from a child with acute flaccid paralysis (AFP) in Sichuan Province in 2019, 3 years after the global withdrawal of live, attenuated type 2 oral poliovirus vaccine (OPV). Investigation followed National Health Commission and World Health Organization guidance and included searching hospitals for unreported AFP cases; testing stool specimens from the child, his contacts, and local children; enhanced environmental surveillance for VDPV2s in wastewater; and measuring vaccination coverage. Sabin-strain IPV campaigns were conducted in a wide geographic area. MAIN OUTCOMES AND MEASURES Any VDPV2 detection after completion of the supplementary immunization activities. RESULTS A 28-nucleotide-change VDPV2 was isolated from a young boy. Three VDPV2s were detected in healthy children; 2 were contacts of the original child, and none had paralysis. A search of 31 million hospital records found 10 unreported AFP cases; none were polio. No type 2 polioviruses were found in wastewater. Prior to the event, polio vaccine coverage was 65% among children younger than 5 years. Sabin-strain IPV campaigns reached more than 97% of targeted children, administering 1.4 million doses. No transmission source was identified. More than 1 year of enhanced poliovirus environmental and AFP surveillance detected no additional VDPVs. CONCLUSIONS AND RELEVANCE These findings suggest that the circulating VPDV2 outbreak in 2019 was associated with low vaccine coverage. An investigation discovered 3 infected but otherwise healthy children and no evidence of the virus in wastewater. Following Sabin-strain IPV-only campaigns expanding from county to prefecture, the poliovirus was not detected, and the outbreak response was considered by an expert panel and the World Health Organization to have been successful. This success suggests that the Sabin-strain IPV may be a useful tool for responding to circulating VDPV2 outbreaks when high-quality supplementary immunization activities can be conducted and carefully monitored in settings with good sanitation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Detection and Initial Response to a Type 2 Vaccine-Derived Poliovirus - Sichuan Province, China, 2019
    Zhou, Jiushun
    Wen, Ning
    Zhang, Yong
    Qi, Qi
    Fan, Chunxiang
    Yan, Dongmei
    Zhu, Xiaoping
    Hao, Lixin
    Zhu, Shuangli
    Liu, Yu
    Ma, Xiaozhen
    Ma, Chao
    Nan, Lei
    Chen, Yong
    Ma, Qianli
    Wang, Cheng
    Deng, Kun
    Cao, Lei
    Shao, Ge
    Ding, Xianxiang
    Yang, Hong
    An, Zhijie
    Rodewald, Lance E.
    Xu, Aiqiang
    Wang, Huaqing
    Feng, Zijian
    Yin, Zundong
    Wu, Xianping
    Xu, Wenbo
    CHINA CDC WEEKLY, 2020, 2 (11): : 172 - 175
  • [2] Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018-2019
    Zhao, Hehe
    Ma, Xiaozhen
    Tang, Haishu
    Zhang, Yong
    Chen, Na
    Kaisaier, Wusiman
    Wang, Qi
    Wang, Cheng
    Zhu, Shuangli
    Qi, Qi
    Liu, Yu
    Ma, Qianli
    Yang, Qing
    Li, Junhan
    Wang, Dongyan
    Li, Xiaolei
    Xiao, Jinbo
    Zhu, Hui
    Xu, Wenbo
    Tong, Wenbin
    Yan, Dongmei
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (12):
  • [3] Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak-Tajikistan
    O'Connor, Patrick
    Huseynov, Shahin
    Nielsen, Carrie F.
    Saidzoda, Faizali
    Saxentoff, Eugene
    Sadykova, Umeda
    Kormoss, Patricia
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (09): : 361 - 362
  • [4] Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement
    Chen, Haiping
    Gao, Zhigang
    Bai, Shuang
    Liu, Xiaoqin
    Han, Shasha
    Xiao, Yanhui
    Liu, Fang
    Yu, Yinghong
    Sun, Hongmei
    Yang, Xiaoming
    VACCINE, 2021, 39 (17) : 2467 - 2474
  • [5] Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021 q
    Snider, Cynthia J.
    Boualam, Liliane
    Tallis, Graham
    Takashima, Yoshihiro
    Abeyasinghe, Rabindra
    Lo, Ying-Ru
    Grabovac, Varja
    Avagyan, Tigran
    Aslam, Syeda Kanwal
    Eltayeb, Abu Obeida
    Aung, Khin Devi
    Wang, Xiaojun
    Shrestha, Achyut
    Ante-Orozco, Carla
    Silva, Maria Wilda T.
    Lapastora-Sucaldito, Nemia
    Apostoli, Lea Necitas G.
    Jika, Muhammad Bin Hj.
    Miraj, Waheed
    Lodhi, Faisal
    Kim, Hyung Joon
    Rusli, Norhayati
    Thorley, Bruce R.
    Kaye, Matthew B.
    Nishimura, Yorihiro
    Arita, Minetaro
    Sani, Jamiatul Aida Md.
    Rundi, Christina
    Feldon, Keith
    VACCINE, 2023, 41 : A58 - A69
  • [6] Limited and Localized Outbreak of Newly Emergent Type 2 Vaccine-Derived Poliovirus in Sichuan, China
    Yan, Dongmei
    Zhang, Yong
    Zhu, Shuangli
    Chen, Na
    Li, Xiaolei
    Wang, Dongyan
    Ma, Xiaozhen
    Zhu, Hui
    Tong, Wenbin
    Xu, Wenbo
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (07) : 1012 - 1018
  • [7] Outbreak Response to Circulating Vaccine-Derived Poliovirus in Three Northern Regions of Ghana, 2019
    Odoom, John Kofi
    Dzotse, Emmanuel Kofi
    Nii-Trebi, Nicholas Israel
    Opare, David
    Akyereko, Ernest
    Attiku, Keren
    Duker, Ewurabena Oduma
    Eshun, Miriam
    Boahene, Bismarck Banahene
    Gberbi, Emmanuel
    Houphouet, Ekua Essumanma
    Diamenu, Stanley
    Adjabeng, Michael
    Asamoah-Frimpong, Joseph
    Ameme, Donne
    Opare, Joseph Kojo Larbi
    Obodai, Evangeline
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [8] Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use - Six African Countries, 2021-2023
    Davlantes, Elizabeth
    Jorba, Jaume
    Henderson, Elizabeth
    Bullard, Kelley
    Deka, Mark. A.
    Kfutwah, Anfumbom
    Martin, Javier
    Bessaud, Mael
    Shulman, Lester M.
    Hawes, Kaija
    Diop, Ousmane M.
    Bandyopadhyay, Ananda S.
    Zipursky, Simona
    Burns, Cara C.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (38): : 1041 - 1042
  • [9] Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
    Hu, Yuemei
    Xu, Kangwei
    Han, Weixiao
    Chu, Kai
    Jiang, Deyu
    Wang, Jianfeng
    Tian, Xiaohui
    Ying, Zhifang
    Zhang, Ying
    Li, Changgui
    Zhu, Fengcai
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (10):
  • [10] Emergence of vaccine-derived poliovirus type 2 after using monovalent type 2 oral poliovirus vaccine in an outbreak response, Philippines
    Alipon, Sweet C. B.
    Takashima, Yoshihiro
    Avagyan, Tigran
    Grabovac, Varja
    Aslam, Syeda Kanwal
    Bayutas, Benjamin
    Logronio, Josephine
    Wang, Xiaojun
    Shrestha, Achyut
    Neupane, Sukadeo
    Roces, Maria Concepcion
    Apostol, Lea Necitas
    Sucaldito, Nemia
    WESTERN PACIFIC SURVEILLANCE AND RESPONSE, 2022, 13 (02)